Sign In
Buy HUM
$349.89
+22.35 (+6.82%)
At Close: Jun 04, 2026
Humana leads S&P 500 decliners after UnitedHealth says seniors are catching up on pandemic-delayed surgeries
11:34am, Wednesday, 14'th Jun 2023
Humana Inc.'s stock HUM tumbled 14% Wednesday, swept up in the downdraft created by UnitedHealth Group Inc.'s UNH disclosure that its senior clients are catching up on hip and knee surgeries that were
Seniors are finally catching up on delayed surgeries. That's bad news for health insurers.
03:52am, Wednesday, 14'th Jun 2023
Seniors are finally catching up on surgery for problems with their knees and hips they delayed during the pandemic — and that means higher costs for health insurers.
Humana (HUM) Wins Contract to Serve Oklahoma's Medicaid Members
12:13pm, Monday, 12'th Jun 2023
Humana (HUM) secures a contract from the OHCA and is likely to provide improved health outcomes for Medicaid members of Oklahoma.
5 HMO Industry Stocks to Watch as Technology Expenses Take a Toll
11:52am, Thursday, 08'th Jun 2023
The Medical-HMO industry is witnessing growth in customer base and an active M&A strategy. However, high technology expenses and medical personnel shortage raise concerns.
Humana (HUM) Arm Reaches 250 Senior Primary Care Facilities
09:48am, Wednesday, 07'th Jun 2023
Humana's (HUM) CenterWell business focuses on providing a better healthcare experience through clubbing primary care, home health and pharmacy services.
Markets Rise Modestly as Semiconductor and Regional Bank Stocks Gain
04:55pm, Tuesday, 06'th Jun 2023
Markets rose modestly on Tuesday, June 6, 2023, as semiconductor and regional bank stocks gained.
CI or HUM: Which HMO Stock is Better Placed at the Moment?
12:10pm, Tuesday, 30'th May 2023
Cigna (CI) and Humana (HUM) are well-positioned to expand in the promising HMO space. Let's try to find out which one fares better via comparative evaluation.
Cloud Stock Improves Bottom Line, Finally Heads For Profitability
02:29pm, Tuesday, 23'rd May 2023
Cloud data streaming stock Confluent is approaching profitability and nears a buy point. This cloud data streaming stock sees a total addressable market hitting $100 billion by 2025.
These stock pickers led the health-fund category over the past 5 years. Here's where they're investing now.
01:59pm, Monday, 22'nd May 2023
The Baron Health Care Fund's first five years have been exceptional in every sense of the word. Launched in spring 2018, the fund has navigated around the COVID-19 pandemic, a biotech initial public o
Walgreens fights 'staggering' $642 mln arbitration award to Humana
12:31pm, Monday, 22'nd May 2023
National retail pharmacy giant Walgreen Co has asked a U.S. judge to vacate an arbitrator's award of more than $642 million to Humana Health Plan Inc in a drug-pricing dispute, calling the "staggering
Here's Why You Should Retain Humana (HUM) in Your Portfolio
01:46pm, Friday, 19'th May 2023
Humana (HUM) remains well-poised for growth, attributable to a growing customer base, numerous contract wins and solid cash-generating abilities.
Humana (HUM) Teams Up With DME Entities to Boost Home Solutions
12:57pm, Friday, 12'th May 2023
These partnerships will equip Humana (HUM) with the means to deploy advanced clinical programs that can reduce hospitalizations for the members.
Here's Why Humana (HUM) is a Strong Value Stock
11:27am, Tuesday, 09'th May 2023
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Humana Inc. to Present at the BofA Securities 2023 Healthcare Conference
04:30pm, Monday, 01'st May 2023
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, President and Chief Executive Officer, and Susan M. Diamond, Chief Financial Officer, will make a pre
Brokers Suggest Investing in Humana (HUM): Read This Before Placing a Bet
10:38am, Monday, 01'st May 2023
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
